Literature DB >> 8287617

Clonal dominance detected in metastases but not primary tumors of retrovirally marked human breast carcinoma injected into nude mice.

K Cornetta1, A Moore, M Johannessohn, G W Sledge.   

Abstract

Human breast cancer cell lines which grow in athymic (nude) mice provide a model of tumor cell growth and metastasis. Marking transplanted tumor cell populations with retroviral vectors provides a means of studying the dynamics of tumor cell growth in vivo. We evaluated three human breast cancer cell lines, MDA-MB-435, MDA-MB-231 and MCF-7, and found the cells were highly susceptible to retroviral gene transfer after a single 2-h exposure (90.9%, 62.7% and 72.3%, respectively). MDA-MB-435 cells (5 x 10(5)) marked with a retroviral vector containing the beta-galactosidase gene (approximately 10(4) uniquely marked clones) were injected into the mammary fat pad of athymic mice to study clonal dominance. Primary tumors resected 10 weeks after injection expressed beta-galactosidase, demonstrating persistent vector expression in vivo. Southern blot analysis did not reveal clonal dominance in the primary tumors of the five mice studied. In contrast, pulmonary metastases in each animal were monoclonal or biclonal. These results demonstrate clonal dominance in pulmonary metastases but not primary tumors of retrovirally marked MDA-MB-435 cells. Our findings suggest that this model may also be used to introduce retroviral vectors expressing oncogenes, and anti-sense oncogenes, to determine their effect on tumor cell proliferation and metastasis in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8287617     DOI: 10.1007/BF01784328

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  32 in total

1.  Amphotropic murine leukemia retrovirus is not an acute pathogen for primates.

Authors:  K Cornetta; R C Moen; K Culver; R A Morgan; J R McLachlin; S Sturm; J Selegue; W London; R M Blaese; W F Anderson
Journal:  Hum Gene Ther       Date:  1990       Impact factor: 5.695

2.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

Authors:  A D Miller; C Buttimore
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

3.  Fate of clonal lineages during neoplasia and metastasis studied with an incorporated genetic marker.

Authors:  B F Moffett; D Baban; L Bao; D Tarin
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

4.  The use of a genotypic marker to demonstrate clonal dominance during the growth and metastasis of a human breast carcinoma in nude mice.

Authors:  J E Price; C Bell; P Frost
Journal:  Int J Cancer       Date:  1990-05-15       Impact factor: 7.396

5.  A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosidase.

Authors:  K Lim; C B Chae
Journal:  Biotechniques       Date:  1989-06       Impact factor: 1.993

6.  lacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis.

Authors:  N Brünner; E W Thompson; M Spang-Thomsen; J Rygaard; K Danø; J A Zwiebel
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

7.  Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations.

Authors:  C Waghorne; M Thomas; A Lagarde; R S Kerbel; M L Breitman
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

8.  Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection.

Authors:  R S Kerbel; C Waghorne; M S Man; B Elliott; M L Breitman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

9.  Genetic tagging of tumor cells with retrovirus vectors: clonal analysis of tumor growth and metastasis in vivo.

Authors:  B Korczak; I B Robson; C Lamarche; A Bernstein; R S Kerbel
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

10.  Early origin and pervasiveness of cellular heterogeneity in some malignant transformations.

Authors:  H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

View more
  7 in total

1.  Correlation of tumor phenotype with c-fms proto-oncogene expression in an in vivo intraperitoneal model for experimental human breast cancer metastasis.

Authors:  Eugene P Toy; Nathalie Bonafé; Asim Savlu; Caroline Zeiss; Wenxin Zheng; Maryann Flick; Setsuko K Chambers
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

2.  Integrin activation controls metastasis in human breast cancer.

Authors:  B Felding-Habermann; T E O'Toole; J W Smith; E Fransvea; Z M Ruggeri; M H Ginsberg; P E Hughes; N Pampori; S J Shattil; A Saven; B M Mueller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

3.  Characterization of spontaneous metastasis in an aggressive breast carcinoma model using flow cytometry.

Authors:  C M Schmidt; S L Settle; J L Keene; W F Westlin; G A Nickols; D W Griggs
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

4.  Acquisition and enhanced expression of the metastatic phenotype following transfections of genomic mouse tumor DNA containing human SCLC gene sequences.

Authors:  C C Cate; D R Belloni; M Marin-Padilla
Journal:  Clin Exp Metastasis       Date:  1995-05       Impact factor: 5.150

5.  Non-glycosylated tandem repeats of MUC1 facilitate attachment of breast tumor cells to normal human lung tissue and immobilized extracellular matrix proteins (ECM) in vitro: potential role in metastasis.

Authors:  Pawel Ciborowski; Olivera J Finn
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

6.  Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer.

Authors:  Anjaiah Srirangam; Ranjana Mitra; Mu Wang; J Christopher Gorski; Sunil Badve; LeeAnn Baldridge; Justin Hamilton; Hiromitsu Kishimoto; John Hawes; Lang Li; Christie M Orschell; Edward F Srour; Janice S Blum; David Donner; George W Sledge; Harikrishna Nakshatri; David A Potter
Journal:  Clin Cancer Res       Date:  2006-03-15       Impact factor: 12.531

7.  Identifying the optimal dose of ritonavir in the treatment of malignancies.

Authors:  Emad Y Moawad
Journal:  Metab Brain Dis       Date:  2013-11-19       Impact factor: 3.584

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.